| 摘要 |
The present invention relates to GLP-1 receptor agonists for use in hypoglycaemia or hypoglycaemic episodes in patients treated with insulin and/or suffering from type 1 diabetes, e.g. for reducing the number of hypoglycaemia or hypoglycaemic episodes. |
